Search Results - "REVEL‐VILK, S."

Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1 by Dardis, A, Michelakakis, H, Rozenfeld, P, Fumic, K, Wagner, J, Pavan, E, Fuller, M, Revel-Vilk, S, Hughes, D, Cox, T, Aerts, J

“…Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder due to the deficient activity of the acid beta-glucosidase (GCase) enzyme, resulting…”
Get full text

Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA‐related Parkinson's disease by Arkadir, D., Dinur, T., Becker Cohen, M., Revel‐Vilk, S., Tiomkin, M., Brüggemann, N., Cozma, C., Rolfs, A., Zimran, A.

“…Background and purpose Individuals with GBA (glucocerebrosidase) mutations are at increased risk of Parkinson's disease (PD). It is still debated, however,…”
Get full text

Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer by Revel‐Vilk, S., Yacobovich, J., Tamary, H., Goldstein, G., Nemet, S., Weintraub, M., Paltiel, O., Kenet, G.

“…BACKGROUND: The use of central venous catheters (CVCs) has greatly improved the quality of care in children with cancer, yet these catheters may cause serious…”
Get full text

Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors: A prospective cohort study by Polen, E., Weintraub, M., Stoffer, C., Jaffe, D.H., Burger, A., Revel-Vilk, S.

“…Background Although the use of central venous catheters (CVCs) has greatly improved the quality of care of children with cancer, these catheters increase the…”
Get full text

Definition of post‐thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations by GOLDENBERG, N. A., BRANDÃO, L. R., JOURNEYCAKE, J., KAHN, S. R., MONAGLE, P., REVEL‐VILK, S., SHARATHKUMAR, A., CHAN, A. K. C.

Get full text

P1633: LOW SERUM BDNF LEVELS ARE ASSOCIATED WITH LOWER PLATELETS’ CD62P REACTIVITY AND INCREASED BLEEDING TENDENCY IN PATIENTS WITH GAUCHER DISEASE by Azoulay, D., Naamad, M., Frydman, D., Broide, E., Zimran, A., Stemer, G., Revel‐Vilk, S.

Get full text

Standardization of post‐thrombotic syndrome definition and outcome assessment following upper venous system thrombosis in pediatric practice by REVEL‐VILK, S., BRANDÃO, L. R., JOURNEYCAKE, J., GOLDENBERG, A., MONAGLE, P., SHARATHKUMAR, A., CHAN, A. K. C.

Get full text

P979: EXOSOMES IN POLYCYTHEMIA VERA: “MINI PLATELETS“ WITH THROMBOGENIC POTENTIAL by Abulafia, A., Spectre, G., Ziv, E., Geiger, K. R., Sarsor, Z., Ron, N., Beery, E., Revel‐Vilk, S., Naamad, M., Raanani, P., Uziel, O., Rozovski, U.

Get full text

Activity of cytochrome P450 1A2 in relation to hepatic iron accumulation in transfusion-dependent β-thalassaemia major patients by Shteyer, E., Nitzan, I., Godfarb, A., Hemed, N., Revel-Vilk, S.

“…Background Cytochrome P450 1A2 (CYP1A2) is a cytochrome enzyme with a pivotal role in hepatic drug metabolism. Data from CYP1A2(−/−) mouse suggest that CYP1A2…”
Get full text

P835: GENETIC BACKGROUND AND CLINICAL CHARACTERISTICS OF CONGENITAL NEUTROPENIAS IN ISRAEL by Steinberg‐Shemer, O., Yeshareem, L., Noy‐Lotan, S., Dgany, O., Krasnov, T., Berger Pinto, G., Bielorai, B., Kuperman, A. A., Laor, R., Mandel‐Shorer, N., Ben Barak, A., Levin, C., Mahdi, A., Miskin, H., Revel‐Vilk, S., Levin, D., Benish, M., Zuckerman, T., Wolach, O., Pazgal, I., Gilad, O., Goldberg, T., Yacobovich, J., Izraeli, S., Tamary, H.

Get full text

Effect of intracranial bleeds on the neurocognitive, academic, behavioural and adaptive functioning of boys with haemophilia by MILES, B. S., ANDERSON, P., AGOSTINO, A., GOLOMB, M. R., ACHONU, C., BLANCHETTE, V., FELDMAN, B. M., McLIMONT, M., REVEL-VILK, S., STAIN, A., BARNES, M. A.

“…Brain insults are a risk factor for neuropsychological and academic deficits across several paediatric conditions. However, little is known about the specific…”
Get full text

Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound by Revel-Vilk, S, Sharathkumar, A, Massicotte, P, Marzinotto, V, Daneman, A, Dix, D, Chan, A

“…Low molecular weight heparin (LMWH) is efficacious in preventing recurrent thromboembolic events (TEs) in children. The efficacy of LMWH in resolving thrombus…”
Get full text

The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity by REVEL-VILK, S., KOMVILAISAK, P., BLANCHETTE, V., STAIN, A. M., FLOROS, G., COCHRANE, A., BLANCHETTE, C., HANG, M., ROBERTS, E. A., LING, S. C.

“…Hepatitis in children with haemophilia was historically most often associated with transfusion‐transmitted infections. However, with the use of recombinant…”
Get full text

Antiphospholipid syndrome and recurrent thrombosis in children by Berkun, Y., Padeh, S., Barash, J., Uziel, Y., Harel, L., Mukamel, M., Revel‐Vilk, S., Kenet, G.

“…Objective Few studies have addressed antiphospholipid syndrome (APS) among children. Our aims were to analyze the clinical and laboratory manifestations in a…”
Get full text

Evaluation of children with a suspected bleeding disorder applying the Impact‐R [Cone and Plate(let) Analyzer] by REVEL‐VILK, S., VARON, D., SHAI, E., AGMON, Y., HYAM, E., DAAS, N., MISKIN, H., WEINTRAUB, M.

“…Background: A convenient screening test for children with bleeding symptoms before more labor‐intensive diagnostic steps are taken would be of value. The…”
Get full text

In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia A by REVEL-VILK, S., BLANCHETTE, V. S., SCHMUGGE, M., CLARK, D. S., LILLICRAP, D., RAND, M. L.

“…Factor VIII (FVIII) replacement by continuous infusion (CI) is used postoperatively or after significant bleeding. For young paediatric patients, CI may…”
Get full text

Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience by Averbuch, D., Avaky, C., Harit, M., Stepensky, P., Fried, I., Ben-Ami, T., Temper, V., Peled, Y., Troen, H., Masarwa, R., Abu Ahmad, W., Weintraub, M., Revel-Vilk, S., Engelhard, D.

“…Purpose Data on non-fermentative Gram-negative rods (NFGNR) bacteremia in children with malignancies are limited. The aim of this study was to present clinical…”
Get full text

Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease by Revel-Vilk, S, Chan, A, Bauman, M, Massicotte, P

“…Venous thromboembolic events (VTEs) in children are usually associated with underlying clinical conditions. The added contribution of prothrombotic conditions…”
Get full text

Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease by Nabhani, Schafiq, Ginzel, Sebastian, Miskin, Hagit, Revel-Vilk, Shoshana, Harlev, Dan, Fleckenstein, Bernhard, Hönscheid, Andrea, Oommen, Prasad T, Kuhlen, Michaela, Thiele, Ralf, Laws, Hans-Jürgen, Borkhardt, Arndt, Stepensky, Polina, Fischer, Ute

“…Autoimmune lymphoproliferative syndrome is frequently caused by mutations in genes involved in the Fas death receptor pathway, but for 20-30% of patients the…”
Get full text

Clinical outcome of umbilical artery catheter-related thrombosis—a cohort study by Ergaz, Z, Simanovsky, N, Rozovsky, K, Leil, S Abu, Ofek-Shlomai, N, Revel-Vilk, S, Bar-Oz, B

“…Objective: To reveal the incidence of umbilical artery catheter-related thrombosis (UACRT), the associated risk factors and the natural history of clot…”
Get full text